Linked Data API

Show Search Form

Search Results

872375
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Blood Cancer: Mental Health Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 21 March 2018 to Question 132195, on Haematological Cancer: Mental Health Services, whether patients diagnosed with blood cancer but not yet starting treatment will be eligible for the Cancer Recovery Package. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 134289 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-03-29more like thismore than 2018-03-29
star this property answer text <p>Every cancer patient will be eligible for the Recovery Package intervention regardless of their treatment status.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-03-29T13:57:20.463Zmore like thismore than 2018-03-29T13:57:20.463Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
872274
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Cancer and Rare Diseases: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of NICE appraisals for new treatments for rare (a) diseases and (b) cancers. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 134188 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-04-03more like thismore than 2018-04-03
star this property answer text <p>Most new drugs and significant licence indications are assessed by the National Institute for Health and Care Excellence (NICE) through its technology appraisal programme, through which NICE has been able to recommend a significant number of drugs for the treatment of rare cancers and other diseases for routine use on the National Health Service. NICE also operates a separate Highly Specialised Technology evaluation programme for the evaluation of a very small number of treatments for very rare diseases.</p><p>The methods and processes NICE uses in the development of its guidance are internationally respected, have been developed through extensive engagement with a full range of stakeholders, including the Department, and are regularly reviewed to ensure that they remain fit for purpose.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-04-03T13:25:57.05Zmore like thismore than 2018-04-03T13:25:57.05Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
872373
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Cancer Drugs Fund more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what drugs have been funded through the Cancer Drugs Fund this year; and how much funding remains in that Fund. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 134287 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-03-29more like thismore than 2018-03-29
star this property answer text <p>Since April 2017, there are currently 27 drugs in 42 indications that are funded by the Cancer Drugs Fund (CDF). A full list of current and previous CDF drugs can be viewed at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/cancer/cdf/cancer-drugs-fund-list/" target="_blank">https://www.england.nhs.uk/cancer/cdf/cancer-drugs-fund-list/</a></p><p> </p><p>The latest published spend for the first six months of 2017/18 implies a circa £76 million of unused funding for that period against the CDF. The quarterly activity report is a snapshot of CDF spend at a point in time and the spend figure will increase as more drugs are added to the fund. The link to the report can be found here:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2018/01/cdf-activity-update-Q2-2017-18.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2018/01/cdf-activity-update-Q2-2017-18.pdf</a></p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-03-29T13:51:19.143Zmore like thismore than 2018-03-29T13:51:19.143Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
872380
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Blood Cancer more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 19 March 2018 to Question 132100, on Haematological Cancer, whether he or NHS England plan to publish information on the work of multidisciplinary diagnostic centres before December 2018. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 134294 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-03-29more like thismore than 2018-03-29
star this property answer text <p>The 10 multidisciplinary diagnostic centres or ‘rapid assessment and diagnostic centres’ have been described in the Progress Report on the cancer strategy published by NHS England in October 2017 at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2017/10/national-cancer-transformation-programme-2016-17-progress.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2017/10/national-cancer-transformation-programme-2016-17-progress.pdf</a></p><p> </p><p>The evaluation of the centres is being undertaken by the Accelerate, Co-ordinate, Evaluate Partnership, which will publish its final report in December 2018.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-03-29T13:55:02.697Zmore like thismore than 2018-03-29T13:55:02.697Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
872376
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Cancer: Nurses more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether every patient diagnosed with cancer receives support from a clinical nurse specialist; and if he will make a statement. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 134290 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-03-29more like thismore than 2018-03-29
star this property answer text <p>The Cancer Patient Experience Survey 2016 results show that 90% of respondents said that they were given the name of a clinical nurse specialist who would support them through their treatment. NHS England is working alongside Health Education England to expand the number of Clinical Nurse Specialists (CNS) and develop clear CNS competencies and routes into training. This will ensure every cancer patient has access to a CNS or other support worker by 2021.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-03-29T13:56:27.02Zmore like thismore than 2018-03-29T13:56:27.02Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
872275
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) NHS England and (b) NICE on the development of (a) multi-indication pricing, (b) outcomes-based pricing and (c) annuity deals for new treatments. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 134189 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-03-29more like thismore than 2018-03-29
star this property answer text <p>The Department has regular and ongoing dialogue with NHS England and the National Institute for Health and Care Excellence on matters related to medicines pricing and patient access to new treatments. We will consider all relevant issues in upcoming discussions with the pharmaceutical industry on medicines pricing arrangements for 2019 onwards to succeed the current Pharmaceutical Price Regulation Scheme.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-03-29T14:02:10.2Zmore like thismore than 2018-03-29T14:02:10.2Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
872272
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Acute Lymphoblastic Leukaemia: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the availability of treatments for patients diagnosed with Refractory B-cell Acute Lymphoblastic Leukaemia. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 134186 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-04-03more like thismore than 2018-04-03
star this property answer text <p>The following treatments are routinely available, having undergone Technical Appraisals by the National Institute for Health and Care Excellence (NICE). They were previously accessible through the Cancer Drugs Fund.</p><p> </p><p>- Blinatumomab for relapsed refractory (r/r) Philadelphia negative acute lymphoblastic leukaemia (ALL); and</p><p>- Ponatinib for Philadelphia positive ALL in patients in whom imatinib is not clinically appropriate (which might cover some r/r).</p><p> </p><p>The following treatments are currently under consideration by NICE:</p><p> </p><p>- CAR-T (Tisagenlecleucel-T and also Axicabtagene ciloleucel) for previously treated B-cell ALL in people aged 3 to 21 at initial diagnosis;</p><p>- Inotuzumab ozogamicin for treating r/r ALL; and</p><p>- Blinatumomab in other extended indications in ALL.</p><p> </p><p>Finally, the following treatments are currently accessible through the Cancer Drugs Fund.</p><p> </p><p>- Clofarabine for treating ALL in children after two therapies; and</p><p>- Nelarabine for treating ALL after two therapies.</p><p> </p><p>Information on the number and proportion of patients with refractory B-cell Acute Lymphoblastic Leukaemia who have been unable to access treatments for that condition is not held centrally.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property grouped question UIN 134187 more like this
star this property question first answered
less than 2018-04-03T13:25:08.103Zmore like thismore than 2018-04-03T13:25:08.103Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
872273
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Acute Lymphoblastic Leukaemia: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many and what proportion of patients with Refractory B-cell Acute Lymphoblastic Leukaemia have been unable to access treatments for that condition. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 134187 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-04-03more like thismore than 2018-04-03
star this property answer text <p>The following treatments are routinely available, having undergone Technical Appraisals by the National Institute for Health and Care Excellence (NICE). They were previously accessible through the Cancer Drugs Fund.</p><p> </p><p>- Blinatumomab for relapsed refractory (r/r) Philadelphia negative acute lymphoblastic leukaemia (ALL); and</p><p>- Ponatinib for Philadelphia positive ALL in patients in whom imatinib is not clinically appropriate (which might cover some r/r).</p><p> </p><p>The following treatments are currently under consideration by NICE:</p><p> </p><p>- CAR-T (Tisagenlecleucel-T and also Axicabtagene ciloleucel) for previously treated B-cell ALL in people aged 3 to 21 at initial diagnosis;</p><p>- Inotuzumab ozogamicin for treating r/r ALL; and</p><p>- Blinatumomab in other extended indications in ALL.</p><p> </p><p>Finally, the following treatments are currently accessible through the Cancer Drugs Fund.</p><p> </p><p>- Clofarabine for treating ALL in children after two therapies; and</p><p>- Nelarabine for treating ALL after two therapies.</p><p> </p><p>Information on the number and proportion of patients with refractory B-cell Acute Lymphoblastic Leukaemia who have been unable to access treatments for that condition is not held centrally.</p>
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property grouped question UIN 134186 more like this
star this property question first answered
less than 2018-04-03T13:25:08.167Zmore like thismore than 2018-04-03T13:25:08.167Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this
872374
star this property registered interest false more like this
star this property date remove filter
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
unstar this property hansard heading Cancer more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many people have accessed the Cancer Recovery Package in the last 12 months; and what proportion of those people had blood cancer. more like this
star this property tabling member constituency Crawley more like this
star this property tabling member printed
Henry Smith remove filter
star this property uin 134288 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-03-29more like thismore than 2018-03-29
star this property answer text <p>This information is not held centrally. NHS England is currently developing plans for national data collection.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-03-29T14:00:43.397Zmore like thismore than 2018-03-29T14:00:43.397Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
3960
unstar this property label Biography information for Henry Smith more like this